SPOTLIGHT: BioMarin, Genzyme restructure pact

BioMarin, Genzyme restructure pact
BioMarin and Genzyme have restructured their pact for Aldurazyme, an enzyme replacement treatment for the rare disease MPS 1. The companies say that the revision will reduce management time and provide stronger incentives for each company. Release